Other News

Rexlemestrocel-L to be Highlighted at Maxim’s Panel on Late-Stage Advancements in Heart Failure Therapeutics and Management

NEW YORK, July 11, 2022 (GLOBE NEWSWIRE) — Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today announced that rexlemestrocel-L, its allogeneic “off-the-shelf” product candidate for the treatment of chronic heart failure (CHF) with reduced ejection fraction (HFrEF), will be highlighted in a panel discussion […]

Story Health Appoints Cardiovascular Changemaker Andrew Sauer, MD to Advisory Board

Renowned Cardiologist and Innovator Brings Unparalleled Expertise to Story Health and Fuels Mission of Transforming Care for Americans with Heart Failure SAN JOSE, Calif.–(BUSINESS WIRE)–Story Health, a health technology and services company that extends specialty care to patients’ homes, today announced the appointment of Dr. Andrew Sauer to its Board […]

Vascular Dynamics Completes $20 Million Equity Financing to Support Further Clinical Evaluations of MobiusHD Device

IRVINE, Calif.–(BUSINESS WIRE)–Vascular Dynamics, Inc. (VDI), a privately held medical device company focused on developing game-changing endovascular device-based solutions for patients suffering from heart failure, has announced the closing of its $20 million financing round led by an investment partner of VDI shareholder Rainbow Medical. Lawrence C. Best also joined existing […]

Shimadzu Medical Systems USA releases the MobileDaRt Evolution MX8 V type, the next evolution of the MobileDaRt Evolution series

TORRANCE, Calif., July 11, 2022 /PRNewswire/ — Shimadzu Medical Systems USA, a subsidiary of Shimadzu Corporation, is proud to announce the release of the MobileDaRt Evolution MX8 Version V type. This product will be showcased at the AHRA (American Healthcare Radiology Administrators) Annual Meeting and Exposition, held in Phoenix, AZ from July 10 to 13, 2022. […]

Inspira™ Technologies Reveals Next Generation Liby™ ECMO, an Extracorporeal Membrane Oxygenation System, Targeting a $531 Million Global ECMO Market

RA’ANANA, Israel, July 11, 2022 /PRNewswire/ — Inspira™ Technologies OXY B.H.N. Ltd. (Nasdaq: IINN, IINNW) (the “Company” or “Inspira Technologies”) introduces today the “Liby™” System, an advanced form of life support better known by the medical industry as extracorporeal membrane oxygenation (ECMO), used to treat patients with life-threatening heart and lung failure. The Liby™ System is intended to […]

Anthos Therapeutics Announces that Abelacimab has Received FDA Fast Track Designation for the Treatment of Thrombosis Associated with Cancer

Abelacimab is a dual-acting fully human monoclonal antibody targeting both Factor XI and Factor XIa with high affinity and selectivity Earlier this year abelacimab became the first-ever Factor XI inhibitor to begin enrolling patients in a Phase 3 trial (The ASTER Study) The AZALEA-TIMI 71 trial in patients with atrial fibrillation […]

Rebecca Cogswell, MD, Named Incoming Medical Director of the International Thoracic Organ Transplant Registry International Society for Heart and Lung Transplantation (PRNewsfoto/The International Society of Heart and Lung Transplantation)

CHICAGO, July 11, 2022 /PRNewswire/ — The International Society for Heart and Lung Transplantation (ISHLT) named Rebecca Cogswell, MD, the Medical Director of the Society’s International Thoracic Organ Transplant (TTX) Registry. The search process was led by the ISHLT Research Oversight Committee, chaired by Jason Christie, MD, MS. Dr. Cogswell is Associate Professor of Medicine, […]

3DR Labs Introduces New Imaging Services to Meet Specific Radiology Market Needs

Its new Cardiac Center of Excellence and Imaging Excellence Advisory Services are designed to support radiology departments nationwide Louisville, KY, July 11, 2022 (GLOBE NEWSWIRE) — 3DR Labs, an Accumen company, today announced the launch of its Cardiac Center of Excellence and Imaging Excellence Advisory Services to support radiology departments […]